Literature DB >> 7238262

BSP clearance as the most reliable criterion of hepatic dysfunction after jejunoileal bypass in the rat: arguments in favor of the existence of a pathogenetic mechanism involving a transient malnutrition state.

J F Grenier, J Marescaux, C Stock, G Coumaros, P Sava, F Michel.   

Abstract

In rats subjected to 90% jejunoileal by-pass or in sham-operated controls, liver function was compared to plasma nutritional state and adaptation of the intestine in continuity over a period of 3 months. While the plasma levels of GOT, GPT, and esterases A and C as cholinesterase C did not differ in either group, the percentage of retention of BSP increased until 8 weeks, then returned progressively to control values 12 weeks after small-bowel bypass. In contrast, plasma nonesterified fatty acid levels decreased significantly until 6 weeks, then recovered control values over the following periods. Plasma total protein and albumin levels also diminished after jejunoileal bypass, the most marked decrease being at the 4th postoperative week. The increase in villus size following the intestinal bypass was considered pronounced for the ileum between the 8th and the 12th week. These results suggest that BSP clearance is the most reliable criterion for hepatic dysfunction in the rat subjected to a jejunoileal bypass. In addition, the parallelism between the variations of BSP clearance, intestinal adaptation, and plasma nutritional state argue for the "nutritional" theory as the most probable explanation for the formation of hepatic lesions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238262     DOI: 10.1007/bf01308375

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Determination of sulfobromophthalein in serum.

Authors:  D SELIGSON; J MARINO; E DODSON
Journal:  Clin Chem       Date:  1957-10       Impact factor: 8.327

2.  Intestinal bypass. A comparison between two different bypass operations and resection of the small intestine in rats.

Authors:  K O Viddal; K Nygaard
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

3.  Bile acid metabolism and hepatic disease following small bowel bypass for obesity.

Authors:  H P Sherr; P P Nair; J J White; J G Banwell; D H Lockwood
Journal:  Am J Clin Nutr       Date:  1974-12       Impact factor: 7.045

4.  [A kinetic method for determination of the activity of pseudocholinesterase (acylcholine acyl-hydrolase 3.1.1.8.)].

Authors:  M Knedel; R Böttger
Journal:  Klin Wochenschr       Date:  1967-03-15

5.  Reversal of severe fatty hepatic infiltration after intestinal bypass for morbid obesity by calorie-free amino acid infusion.

Authors:  S L Heimburger; E Steiger; P Lo Gerfo; A G Biehl; M J Williams
Journal:  Am J Surg       Date:  1975-03       Impact factor: 2.565

6.  Complications of surgery for morbid obesity.

Authors:  R H Gourlay; C Reynolds
Journal:  Am J Surg       Date:  1978-07       Impact factor: 2.565

7.  Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. A study of technical and metabolic features.

Authors:  K N Jeejeebhoy; W J Zohrab; B Langer; M J Phillips; A Kuksis; G H Anderson
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

8.  Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity.

Authors:  E Mezey; A L Imbembo; J J Potter; K C Rent; R Lombardo; P R Holt
Journal:  Am J Clin Nutr       Date:  1975-11       Impact factor: 7.045

9.  Liver dysfunction following small-bowel bypass for obesity. Nonoperative treatment of fatty metamorphosis with parenteral hyperalimentation.

Authors:  F C Ames; E M Copeland; D C Leeb; D L Moore; S J Dudrick
Journal:  JAMA       Date:  1976-03-22       Impact factor: 56.272

10.  Hepatic effects of jejunoileal bypass for morbid obesity.

Authors:  R T Holzbach
Journal:  Am J Clin Nutr       Date:  1977-01       Impact factor: 7.045

View more
  1 in total

1.  Small bowel bypass prevents the trophic action of cholecystokinin on the rat pancreas.

Authors:  C Stock-Damgé; M Aprahamian; E Lhoste; J Marescaux; E Loza
Journal:  Int J Pancreatol       Date:  1987-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.